SCHEMBL21710641

SCHEMBL21710641

c1ccc(-c2c3ccccc3c(-c3ccc4c(c3)c3cccc5c6ccccc6n4c53)c3ccccc23)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.39
KMT2A Q03164 4/20 0.39
MEN1 O00255 2/20 0.39
ALDH1A1 P00352 2/20 0.39
MAPT P10636 2/20 0.39
HPGD P15428 2/20 0.39
HTT P42858 2/20 0.39
POLB P06746 1/20 0.39
TSPO P30536 2/20 0.38
NPY5R Q15761 2/20 0.36
ALKBH5 Q6P6C2 1/20 0.35
FTO Q9C0B1 1/20 0.35
L3MBTL1 Q9Y468 2/20 0.33
ESR1 P03372 2/20 0.33
ESR2 Q92731 2/20 0.33
HSD17B10 Q99714 2/20 0.33
LMNA P02545 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
ACHE P22303 1/20 0.33
ATM Q13315 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21717815 0.90 TSPO (0.46) KDM4EKMT2AMEN1ALDH1A1MAPT
SCHEMBL23138556 0.90 TSPO (0.46) KDM4EKMT2AMEN1ALDH1A1MAPT
SCHEMBL17705009 0.90 TSPO (0.46) KDM4EKMT2AMEN1ALDH1A1MAPT
SCHEMBL21718100 0.89 ESR1 (0.44) KDM4EMAPTTSPONPY5RL3MBTL1
SCHEMBL21126737 0.89 KDM4E (0.38) KDM4EKMT2AMEN1ALDH1A1MAPT
SCHEMBL25459799 0.89 TSPO (0.43) KDM4EKMT2AMEN1ALDH1A1MAPT
SCHEMBL25459798 0.89 TSPO (0.43) KDM4EKMT2AMEN1ALDH1A1MAPT
SCHEMBL24078818 0.89 TSPO (0.43) KDM4EKMT2AMEN1ALDH1A1MAPT
SCHEMBL24841125 0.89 TSPO (0.43) KDM4EKMT2AMEN1ALDH1A1MAPT
SCHEMBL21126569 0.88 KDM4E (0.40) KDM4EKMT2AMEN1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12029119-B2 Organic electroluminescence element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2024-07-02 US disclosed
US-11723272-B2 Organic electroluminescence element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2023-08-08 US disclosed
US-11723272-B2 Organic electroluminescence element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2023-08-08 US disclosed
US-20220013737-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2022-01-13 US disclosed
US-20210005826-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC APPARATUS IDEMITSU KOSAN CO., LTD. (JP) 2021-01-07 US disclosed
US-20210005825-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2021-01-07 US disclosed
US-20200052225-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2020-02-13 US disclosed
US-20200052212-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2020-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12029119-B2 Organic electroluminescence element and electronic device LEF1, L1CAM, ESR2 KDM4E 2210/4885KMT2A 2275/4885MEN1 1680/4885
US-20200052225-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE LEF1, L1CAM, ESR2 KDM4E 2210/4885KMT2A 2275/4885MEN1 1680/4885
US-20210005825-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE OR51E2, CD99, CTNND1 KDM4E 2086/4885KMT2A 2064/4885MEN1 2275/4885
US-20210005826-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC APPARATUS EML4, EBPL, LEF1 KDM4E 2270/4885KMT2A 2258/4885MEN1 2867/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.